ALLMedicine™ Radical Prostatectomy Center

May 4th, 2021 - The presence of invasive cribriform adenocarcinoma (ICC), an expanse of cells containing punched-out lumina uninterrupted by stroma, in radical prostatectomy (RP) specimens has been associated with biochemical recurrence (BCR). However, ICC identi...

May 4th, 2021 - To assess the intermodality and intertracer variability of gallium-68 (68Ga)- or fluorine-18 (18F)-labeled prostate-specific membrane antigen (PSMA) positron emission tomography (PET) and biparametric magnetic resonance imaging (bpMRI)-based gross...

May 4th, 2021 - There has been a limited number of reports on the significance and risk factors of urethrovesical anastomotic urinary leakage (AUL) following robot-assisted radical prostatectomy (RARP). We aimed to analyze the clinical significance of AUL and eva...

May 3rd, 2021 - The comparative effectiveness of surgery and radiation therapy for high-grade, clinically localized prostate cancer remains a seminal, open question in urologic oncology, with no randomized controlled trials to inform management. We therefore emul...

May 3rd, 2021 - The hypersensitive prostate specific antigen (PSA) test can measure in 0.01 ng/mL units, and its efficacy for screening after radical prostatectomy (RP) has been reported. In this study, we assessed patients who underwent RP to evaluate whether th...

May 31st, 2020 - Rana R. McKay, MD, of the University of California, San Diego, discusses the results of a phase II trial of intense neoadjuvant hormone therapy followed by radical prostatectomy in men with high-risk prostate cancer. The data show that 21% of pati...

Apr 29th, 2019 - The purpose of this guideline is to provide direction to clinicians and patients regarding the use of radiotherapy after radical prostatectomy in the adjuvant or salvage setting. The strategies and approaches recommended in the guideline were deri...

Feb 10th, 2019 - Historically, most patients with low-risk prostate cancer (clinical category T1c-T2a, prostate-specific antigen level <10 ng/mL, and Gleason 6 disease) were treated with radical prostatectomy, while radiotherapy-based treatment was the favored app...

May 4th, 2018 - Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men ...

May 19th, 2017 - For patients with low-risk prostate cancer who require or choose active treatment, low–dose rate brachytherapy (LDR) alone, EBRT alone, and/or radical prostatectomy (RP) should be offered to eligible patients. For patients with intermediate-risk p.

May 4th, 2021 - The presence of invasive cribriform adenocarcinoma (ICC), an expanse of cells containing punched-out lumina uninterrupted by stroma, in radical prostatectomy (RP) specimens has been associated with biochemical recurrence (BCR). However, ICC identi...

May 4th, 2021 - To assess the intermodality and intertracer variability of gallium-68 (68Ga)- or fluorine-18 (18F)-labeled prostate-specific membrane antigen (PSMA) positron emission tomography (PET) and biparametric magnetic resonance imaging (bpMRI)-based gross...

May 4th, 2021 - There has been a limited number of reports on the significance and risk factors of urethrovesical anastomotic urinary leakage (AUL) following robot-assisted radical prostatectomy (RARP). We aimed to analyze the clinical significance of AUL and eva...

May 3rd, 2021 - The comparative effectiveness of surgery and radiation therapy for high-grade, clinically localized prostate cancer remains a seminal, open question in urologic oncology, with no randomized controlled trials to inform management. We therefore emul...

May 3rd, 2021 - The hypersensitive prostate specific antigen (PSA) test can measure in 0.01 ng/mL units, and its efficacy for screening after radical prostatectomy (RP) has been reported. In this study, we assessed patients who underwent RP to evaluate whether th...

Feb 21st, 2021 - NEW YORK (Reuters Health) - The Decipher genomic classifier (GC) is a promising tool to help determine which men will benefit from hormone therapy in addition to salvage radiation after radical prostatectomy, researchers say. "These findings are t...

Jan 27th, 2021 - (Reuters Health) - Patient-reported urinary outcomes three months after radical prostatectomy vary by patient and by surgeon, and a new study suggests that outcomes may be better with top-performing surgeons. Researchers examined data from the Mic...

Oct 29th, 2020 - NEW YORK (Reuters Health) - Men with localized prostate cancer, especially those who undergo radical prostatectomy, have generally worse long-term self-reported quality of life than men without a diagnosis of prostate cancer, according to new rese...

Oct 29th, 2020 - NEW YORK (Reuters Health) - Men with localized prostate cancer, especially those who undergo radical prostatectomy, have generally worse long-term self-reported quality of life than men without a diagnosis of prostate cancer, according to new rese...

Oct 26th, 2020 - NEW YORK (Reuters Health) - The "hood" technique for robot-assisted prostatectomy enabled a return to continence within four months, without compromising surgical margins, in a single-center, single-surgeon study. "The clinical findings show that ...